Yamaguchi K, Bang YJ, Iwasa S, Sugimoto N, et al. Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2
Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low
Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results
in a Phase II Trial. J Clin Oncol 2023;41:816-825.
PMID: 36379002